Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
Saved in:
Main Authors: | Jennifer E. Yeh, PhD (Author), William G. Tsiaras, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pyoderma gangrenosum faciale in a patient with Crohn's disease
by: Timothy Arleo, BS, et al.
Published: (2020) -
Resolution of therapy-resistant pyoderma gangrenosum with upadacitinib
by: Lisa Van Eycken, MD, et al.
Published: (2023) -
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn's disease
by: Klaudia Miklusiak, et al.
Published: (2023) -
The effect of comorbid autoimmune gastrointestinal diseases on time to resolution of pyoderma gangrenosum: A retrospective review
by: Hugh Nymeyer, MD, PhD, et al.
Published: (2023) -
Progression of pyoderma gangrenosum with angioinvasive fungus
by: Delice Kayishunge, BS, et al.
Published: (2021)